Advanced Gastrointestinal Stromal Tumors
3 clinical trials · Condition
◉ Watch Advanced Gastrointestinal Stromal Tumors
| Record | Firm | Date |
|---|---|---|
| (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors (NCT05208047) | Cogent Biosciences, Inc. | 2022-04-14 |
| Efficacy and Safety of PD-0332991 in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (NCT01907607) | Institut Bergonié | 2014-02-01 |
| A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors (NCT00940563) | Novartis Pharmaceuticals | 2002-03-01 |
Track Advanced Gastrointestinal Stromal Tumors automatically
Every clearance here is in the API, with alerts when new ones post.